448 studies found for:    Open Studies | "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Recruiting Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cancer, Adult;   Liver Cell Carcinoma, Adult
Intervention: Drug: TKM-080301
22 Unknown  the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
Conditions: Stage I Hepatocellular Carcinoma;   Stage II Hepatocellular Carcinoma
Interventions: Drug: the ginsenoside Rg3;   Drug: Placebo
23 Unknown  Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
24 Recruiting A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: LY2157299;   Drug: Sorafenib
25 Not yet recruiting MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Marker, Biological
Intervention:
26 Recruiting Circulating Tumor Cells for Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Neoplasm Circulating Cells
Intervention:
27 Recruiting Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Huachansu;   Other: TACE
28 Recruiting A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Lipotecan® (TLC388)
29 Recruiting Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Regorafenib (BAY73-4506);   Drug: Placebo
30 Recruiting Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: 5-FU;   Drug: Mitomycin;   Drug: sorafenib
31 Recruiting Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Biological: OBP-301
32 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
33 Unknown  The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LMWH;   Procedure: TACE
34 Not yet recruiting Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Condition: Carcinoma, Hepatocellular
Interventions: Drug: TACE containing As2O3;   Drug: TACE containing placebo
35 Recruiting TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
36 Unknown  Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: Radiofrequency ablation;   Procedure: TACE
37 Recruiting Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Conditions: Adult Hepatocellular Carcinoma;   Recurrent Hepatocellular Carcinoma;   Adverse Reaction to Drug;   Vascular Endothelial Growth Factor Overexpression
Interventions: Drug: thalidomine;   Drug: tegafur-uracil
38 Recruiting 188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas
Condition: Hepatocellular Carcinomas
Intervention: Drug: 188Re-SSS Lipiodol
39 Recruiting Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Other: transarterial chemoembolization(TACE);   Other: Transarterial chemoembolization (TACE)
40 Recruiting Transarterial Chemoembolization With or Without Lipiodol Chemotherapy in Patient With Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Other: Procedure:Transarterial embolization;   Other: Procedure/Surgery: Transarterial infusion chemotherapy;   Other: Transarterial lipiodol chemotharepy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years